Page last updated: 2024-08-24

plerixafor and Liver Dysfunction

plerixafor has been researched along with Liver Dysfunction in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blanchard, J; Caldwell, CC; Edwards, MJ; Freeman, CM; Kuethe, JW; Lentsch, AB; Nojima, H; Quillin, RC; Schuster, R; Wilson, GC1

Other Studies

1 other study(ies) available for plerixafor and Liver Dysfunction

ArticleYear
CXC chemokine receptor-4 signaling limits hepatocyte proliferation after hepatic ischemia-reperfusion in mice.
    American journal of physiology. Gastrointestinal and liver physiology, 2015, Apr-15, Volume: 308, Issue:8

    Topics: Adoptive Transfer; Animals; Benzylamines; Cell Proliferation; Cells, Cultured; Chemokine CXCL12; Cyclams; Disease Models, Animal; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Hepatocytes; Heterocyclic Compounds; Leukocyte Common Antigens; Leukocytes, Mononuclear; Liver; Liver Diseases; Liver Regeneration; Male; Mice, Inbred C57BL; Receptors, CXCR4; Reperfusion Injury; Signal Transduction; Time Factors

2015